imatinib mesylate has been researched along with Hypersensitivity in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Krishnamoorthy, N; Oriss, TB; Ray, A; Ray, P | 1 |
| Di, YW; Liu, YH; Zhuang, HG | 1 |
| Gross, WL; Hellmich, B; Holl-Ulrich, K | 1 |
2 review(s) available for imatinib mesylate and Hypersensitivity
| Article | Year |
|---|---|
Dendritic cell c-kit signaling and adaptive immunity: implications for the upper airways.
Topics: Adaptive Immunity; Animals; Benzamides; Cytokines; Dendritic Cells; Humans; Hypersensitivity; Imatinib Mesylate; Killer Cells, Natural; Lymphocyte Activation; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Respiratory System; Signal Transduction; Stem Cell Factor; Th1-Th2 Balance; Th17 Cells; Th2 Cells | 2014 |
[Hypereosinophilic syndrome--recent developments in diagnosis and treatment].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzamides; Glucocorticoids; Humans; Hypereosinophilic Syndrome; Hypersensitivity; Imatinib Mesylate; Immunosuppressive Agents; Interferon-alpha; Lung Diseases; Neoplasms; Parasitic Diseases; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Tumor Necrosis Factor-alpha; Vasculitis | 2007 |
1 other study(ies) available for imatinib mesylate and Hypersensitivity
| Article | Year |
|---|---|
[Eosinophils and related diseases].
Topics: Antineoplastic Agents; Autoimmune Diseases; Benzamides; Cell Differentiation; Cell Movement; Cell Survival; Eosinophilia; Eosinophils; Helminthiasis; Humans; Hypereosinophilic Syndrome; Hypersensitivity; Imatinib Mesylate; Piperazines; Pyrimidines | 2009 |